INS and Hyperinsulinemia: As discussed by the authors, although hyperinsulinemia may be a risk factor for atheromatosis, a reasonable daily amount of insulin used for treatment and properly adjusted to diurnal glucose variability can attenuate the severity and progression of vascular damage.